所長ごあいさつ｜新宿追分クリニック/新宿追分クリニック・レディース

所長略歴

北里大学医学部卒業早稲田大学LRC修了
ブリティッシュコロンビア大学 Visiting Scientist
東京医科大学病院内科外来総医長
東京医科大学兼任講師
東京医科大学地域医療指導教授
東都大学客員教授

認定・資格

医学博士（東京医科大学）
日本医師会認定産業医
日本内科学会認定医・総合内科専門医
日本呼吸器学会呼吸器専門医・指導医
日本人間ドック学会/日本総合健診医学会認定医・健診専門医・指導医
日本人間ドック学会遺伝学的検査アドバイザー
JAF国内競技運転者許可証（国内A級）

業績（英文）

1. Kasuga I, Ohtsubo O. Actual situation on low-dose computed tomography screening for thoracic diseases at health checkup. Acta Scientific Medical Sciences 2024; 8(8): 120-130.
2. Kasuga I, Yokoe Y, Gamo S, Sugiyama T, Noguchi M, Tokura M, Okayama M, Ohmori N, Takeda Y, Sato T, Nakashima I, Wakabayashi K, Yamamoto S, Ohtsubo O. Antimicrobial effect using air catalyst in Healthcare Facility: A 3-year analyzing report. Acta Scientific Microbiology 2024; 7(7):10-16. (Best article award of the issue)
3. Kasuga I, Yokoe Y, Gamo S, Sugiyama T, Tokura M, Noguchi M, Okayama M, Nagakura R, Ohmori N, Tsuchiya T, Sofuni A, Itoi T, Ohtsubo O. Which is a real valuable screening tool for lung cancer and measure thoracic diseases, chest radiography or low-dose computed tomography? A review on the current status of Japan and other countries. Medicine 2024; 103(19): e 38161.
4. Kasuga I, Yokoe Y, Gamo S, Sugiyama T, Noguchi M, Tokura M, Okayama M, Nagakura R, Tsuchiya T, Sofuni A, Itoi T, Ohtsubo O. Measures against infection on facilities using air catalysis. Asian Journal of Biotechnology and Bioresource Technology 2023; 9(1): 1-6.
5. Kasuga I, Yokoe Y, Ishii Y, Ohtsubo O. Monthly fluctuation of spike protein-specific IgG antibody level against COVID-19 after COVID-19 vaccination and booster shot. Integrative Journal of Nursing and Medicine 2022; 3(3): 1-4.
6. Kasuga I, Maezawa H, Gamo S, Yokoe Y, Yanagihara Y, Sugiyama T, Tokura M, Okayama M, Ohtsubo O. Evaluation of Chest Radiography and Low-dose Computed Tomography as Valuable Screening Tools for Thoracic Diseases. Medicine 2022; 101(29): e 29261.
7. Kasuga I, Gamo S, Yokoe Y, Sugiyama T, Tokura M, Noguchi M, Okayama M, Takeda Y, Sato T, Mori M, Ohtsubo O. Antibody levels over time against the novel coronavirus and incidence of adverse reaction after vaccination. Health Evaluation and Promotion 2022; 49(4): 462-469.
8. Kasuga I, Maezawa H, Okuyama A, Taira M, Gamou S, Takahashi D, Ohtsubo O, Takahashi M. Usability of low-dose spiral computed tomography in the early detection of lung and mediastinal tumors. Health Evaluation and Promotion 2017; 44(4): 575-579.
9. Kasuga I, Oshida N, Kobayashi M, Fukui T, Takahashi D, Xu H, Kawamura I. Prevalence of metabolic syndrome determined on the basis of direct visceral fat area measurement using computed tomography. Health Evaluation and Promotion 2011; 38(4): 532-536.
10. Kasuga I, Hogg JC, Paré PD, Hayashi S, Sedgwick EG, Ruan J, Wallace AM, He JQ, Zhang X, Sandford AJ. Role of genetic susceptibility to latent adenoviral infection and decreased lung function. Respiratory Medicine 2009; 103(11): 1672-1680.
11. Kasuga I, Paré PD, Sandford AJ. Specific genotyping of human leukocyte antigen-A*01 by polymerase chain reaction using allele group-specific primers. Genetics and Molecular Biology 2006: 29(2): 203-206.
12. Kasuga I, Ruan J, Connett JE, Anthonisen NR, Sandford AJ. Lack of association of human leukocyte antigen-B7 with COPD and rate of decline in lung function. Respiratory Medicine 2005; 99(12): 1528-1533.
13. Kasuga I, Paré PD, Ruan J, Connett JE, Anthonisen NR, Sandford AJ. Lack of association of group specific component haplotypes with lung function in smokers. Thorax 2003; 58(9): 790-793.
14. He JQ, Kasuga I, Paré PD: Genetics of COPD. Chap. VII Pharmacotherapy in Chronic Obstructive Pulmonary Disease. Editor: Bartolome RC. Boca Raton: CRC Press, 2003, 119-144.
15. Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Utsumi K, Aoshima M, Ohyashiki K. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. International Journal of Oncology 2003; 23(3): 627-632.
16. Kunisawa A, Kawanishi Y, Tago H, Nagate A, Kasuga I, Ohyashiki K.Direct demonstration of the productive capability of cytokines at the single cell level in lung sarcoidosis using multicolor cytometry. Respiration 2002; 69(2): 155-164.
17. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 92(9); 2001: 2399-2405.
18. Kasuga I, Ishizuka S, Minemura K, Utsumi K, Serizawa H, Ohyashiki K. Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor. Chest 2001; 119(3): 981-983.
19. Nagate A, Ohyashiki JH, Kasuga I, Minemura K, Abe K, Yamamoto K, Ohyashiki K. Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia. International Journal of Molecular Medicine 2001, 8(4): 379-383.
20. Kurakawa E, Kasuga I, Ishizuka S, Yoshida T, Kunisawa A, Minemura K, Utsumi K, Ohyashiki K. Interstitial pneumonia possibly due to a novel anticancer drug, TS-1: first case report. Japanese Journal of Clinical Oncology 2001; 31(6): 284-286.
21. Kasuga I, Minemura K, Nasu H, Hibi N, Tago H, Nagate A, Kunisawa A, Ohyashiki JH, Ohyashiki K. Elevated serum soluble CD44 level in sarcoidosis. International Journal of Molecular Medicine 2000; 6(6): 679-682.
22. Kiyokawa H, Yonemaru M, Horie S, Kasuga I, Ichinose Y, Toyama K. Detection of nocturnal wheezing in bronchial asthma using intermittent sleep tracheal sounds recording. Respirology 1999; 4(1): 37-45.
23. Kasuga I, Miyamoto D, Ichinose Y, Chimangul W, Minemura K, Utsumi K, Yonemaru M, Serizawa H, Ebihara Y, Toyama K. Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis. European Respiratory Journal 1998; 11(5): 1185-1187.
24. Kikawada M, Ichinose Y, Kunisawa A, Yanagisawa N, Minemura K, Kasuga I, Yonemaru M, Kawanishi K, Takasaki M, Toyama K. Sarcoidosis induced by interferon therapy for chronic myelogenous leukemia. Respirology 1998; 3(1): 41-44.
25. Yonemaru M, Kasuga I, Kusumoto H, Kunisawa A, Kiyokawa H, Kuwabara S, Ichinose Y, Toyama K. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. European Respiratory Journal 1997; 10(9): 2040-2045.
26. Kasuga I, Yanagisawa N, Takeo C, Koga M, Kiyokawa H, Yonemaru M, Ichinose Y, Toyama K. Multiple pulmonary nodules in association with pyoderma gangrenosum. Respiratory Medicine 1997; 91(8): 493-495.
27. Yonemaru M, Kasuga I, Kusumoto H, Kiyokawa H, Kuwabara S, Ichinose Y, Toyama K. Protein kinase inhibitor attenuates an increase in endothelial monolayer permeability induced by tumour necrosis factor-alpha. Respirology 1997; 2(1): 63-69.
28. Kasuga I, Yonemaru M, Kiyokawa H, Ichinose Y, Toyama K. Clinical evaluation of serum type IV collagen 7S in idiopathic pulmonary fibrosis. Respirology 1996; 1(4): 277-281. （Thesis）
29. Kiyokawa H, Utsumi K, Minemura K, Kasuga I, Torii Y, Yonemaru M, Ichinose Y, Toyama K. Fat embolism syndrome caused by vegetable oil injection. Internal Medicine 1995; 34(5): 380-383.
30. Yonemaru M, Mizuguchi Y, Kasuga I, Utsumi K, Ichinose Y, Toyama K. Hilar and mediastinal lymphadenopathy with hypersensitivity pneumonitis induced by penicillin. Chest 1992; 102(6): 1907-1909.
31. Kasuga I. Current status on lung cancer screening by chest radiography and low-dose computed tomography. Journal of Advances in Medical and Biomedical Research. （Accepted manuscript）